DNA analysis using the APEX technology

In a pool of different technologies developed for the DNA screening APEX stands out for its unique approach for targeted analysis. In this short 3D animation clip https://www.youtube.com/watch?v=UisFrD2AEII you can see the whole process in practice starting from the DNA already extracted from blood till the final data analysis. For either the medical purposes or just research screening ones the selection of the right technology can be crucial. In case your planned project involves many genes and different sites from them then APEX technology is a good choice as it is well suited for already characterized genetic markers and operates with well-known information.

In addition to APEX we have also adapted NextGen and Sanger sequencing to our services. Whilst APEX allows simultaneous, cost effective detection of hundreds DNA alterations in many different genes and as an addition to the panel of genetic tests that are currently available on our website https://www.asperbio.com/genetic-tests we are always open to offer our expertise in  developing new state-of-the-art genetic tests for common and rare genetic diseases. Just contact Asper Biotech and we’ll discuss your project with our scientific team.

PS. In case you would like to know more about the comparison of two different technologies please take a look at a blog post http://www.genorama.com/EN/about-genorama/blog/validated-microarray-based-genorama-apex-technology-has-its-niche-in-the-diagnostic-lab/ by our sister company Genorama. The post compares the two approaches and elucidates how one can merge both technologies.

New article on CSNB testing

An article on congenital stationary night blindness (CSNB) by Dr. Zeitz and three scientists from Asper Biotech was just published in Methods in Molecular Biology (Methods Mol Biol. 2013;963:319-26.). The article describes APEX-based method for the analysis of mutations associated with CSNB.

Details for the article: Arrayed primer extension microarray for the analysis of genes associated with congenital stationary night blindness Vaidla K, Uksti J, Zeitz C, Oitmaa E. Methods Mol Biol. 2013;963:319-26.